These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8866245)

  • 1. Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin.
    Scarcériaux V; Souazé F; Bachelet CM; Forgez P; Bourdel E; Martinez J; Rostène W; Pélaprat D
    J Neuroendocrinol; 1996 Aug; 8(8):587-93. PubMed ID: 8866245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures.
    Scarcériaux V; Pélaprat D; Forgez P; Lhiaubet AM; Rostène W
    Endocrinology; 1995 Jun; 136(6):2554-60. PubMed ID: 7750477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids down-regulate lipopolysaccharide-induced de novo production of neurotensin mRNA in the rat hypothalamic, paraventricular, corticotrophin-releasing hormone neurons.
    Loum-Ribot E; Lafon P; Chaigniau M; Tramu G; Corio M
    Neuroimmunomodulation; 2006; 13(3):170-8. PubMed ID: 17183192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct inhibitory effect of glucocorticoids on corticotrophin-releasing hormone gene expression in neurones of the paraventricular nucleus in rat hypothalamic organotypic cultures.
    Bali B; Ferenczi S; Kovács KJ
    J Neuroendocrinol; 2008 Sep; 20(9):1045-51. PubMed ID: 18624927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist induced conformation alteration of neurotensin receptor and the mechanism behind Na+ inhibition of 125I-NT binding.
    Mitra SP; Carraway RE; Blute R; Luber-Narod J
    J Recept Signal Transduct Res; 1999 Nov; 19(6):995-1021. PubMed ID: 10533985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
    Donato di Paola E; Cusack B; Yamada M; Richelson E
    J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bowel resection and neurotensin treatment. Histochemical study of neurotensin-like and somatostatin-like immunoreactivities and receptors.
    Toledano A; Rodríguez-Arellano JJ; Gómez de Segura IA; De Miguel E; Martínez-Rodríguez R
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1145-58. PubMed ID: 8997519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
    Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
    Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and internalization of neurotensin in hybrid cells derived from septal cholinergic neurons.
    Faure MP; Labbé-Jullié C; Cashman N; Kitabgi P; Beaudet A
    Synapse; 1995 Jun; 20(2):106-16. PubMed ID: 7570339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common quantitative trait loci for alcohol-related behaviors and central nervous system neurotensin measures: hypnotic and hypothermic effects.
    Erwin VG; Markel PD; Johnson TE; Gehle VM; Jones BC
    J Pharmacol Exp Ther; 1997 Feb; 280(2):911-8. PubMed ID: 9023306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
    Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
    J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.
    Lépée-Lorgeoux I; Betancur C; Souazé F; Rostène W; Bérod A; Pélaprat D
    J Neurosci Res; 2000 May; 60(3):362-9. PubMed ID: 10797539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin modulates central muscarinic receptors, an effect which does not involve the high-affinity neurotensin receptor (NTS1).
    Schneider PG; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Regul Pept; 2010 Aug; 163(1-3):37-42. PubMed ID: 20403392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.
    Wang L; Friess H; Zhu Z; Graber H; Zimmermann A; Korc M; Reubi JC; Büchler MW
    Clin Cancer Res; 2000 Feb; 6(2):566-71. PubMed ID: 10690540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1beta regulation of BDNF expression in rat cultured hypothalamic neurons depends on the presence of glial cells.
    Rage F; Silhol M; Tapia-Arancibia L
    Neurochem Int; 2006 Oct; 49(5):433-41. PubMed ID: 16621158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
    Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
    Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
    Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
    Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.